Thomas Brezicka
Impact in
-
- SARS-CoV-2 detection and testing
- SARS-CoV-2 and COVID-19 Research
-
- Immunotherapy and Immune Responses
- Galectins and Cancer Biology
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 6
-
- Glycosylation and Glycoproteins Research 6
- Co-authors
- Pam Fredman (3 shared papers)Bengt Bergman (2 shared papers)Magnus Lindh (1 shared paper)Martin Lagging (2 shared papers)Ann E. Mattsson (1 shared paper)Leif Dotevall (2 shared papers)Heléne Norder (2 shared papers)Björn Lundin (1 shared paper)
- Journals
- Scientific Reports (2 papers)Cancer Immunology Immunotherapy (2 papers)iScience (1 paper)BMJ Open (1 paper)Lung Cancer (1 paper)
- Partner nations
- SwedenUnited States
In The Last Decade
Thomas Brezicka
16 papers receiving 359 citations
Peers
Comparison fields: 5 of 78
- Infectious Diseases 110
- Immunology 108
- Radiology, Nuclear Medicine and Imaging 80
- Oncology 74
- Molecular Biology 156
Countries citing papers authored by Thomas Brezicka
This map shows the geographic impact of Thomas Brezicka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Brezicka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Brezicka more than expected).
Fields of papers citing papers by Thomas Brezicka
This network shows the impact of papers produced by Thomas Brezicka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Brezicka. The network helps show where Thomas Brezicka may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Brezicka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 109 | |
| 2 | 2003 | 75 | |
| 3 | 2005 | 43 | |
| 4 | 2006 | 33 | |
| 5 | 1986 | 31 | |
| 6 | 2000 | 29 | |
| 7 | 2005 | 13 | |
| 8 | 2022 | 8 | |
| 9 | 2000 | 5 | |
| 10 | 2021 | 4 | |
| 11 | 2001 | 4 | |
| 12 | 2023 | 4 | |
| 13 | 2022 | 4 | |
| 14 | 2022 | 2 | |
| 15 | 2024 | 1 | |
| 16 | 2022 | 1 |
About Thomas Brezicka
Thomas Brezicka is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology, Immunology, Infectious Diseases and Clinical Psychology, having authored 16 papers that have together received 366 indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), Medical Malpractice and Liability Issues (2 papers), Galectins and Cancer Biology (2 papers), Complement system in diseases (2 papers), SARS-CoV-2 detection and testing (2 papers), Lung Cancer Research Studies (2 papers) and Mental Health Research Topics (2 papers). The work is most often cited by research in Infectious Diseases (110 citations), Immunology (108 citations), Radiology, Nuclear Medicine and Imaging (80 citations), Oncology (74 citations) and Molecular Biology (156 citations). Thomas Brezicka has collaborated with scholars based in Sweden and United States. Frequent co-authors include Pam Fredman, Bengt Bergman, Magnus Lindh, Martin Lagging, Ann E. Mattsson, Leif Dotevall, Heléne Norder, Björn Lundin, Magnus Gisslén and Kristina Nystrôm. Their work appears in journals such as Scientific Reports, Cancer Immunology Immunotherapy, iScience, BMJ Open and Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.